FDA Approves Susvimo for Diabetic Macular Edema

WEDNESDAY, Feb. 5, 2025-- The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic...